Bevacizumab for treating HHT patients with severe hepatic involvement or refractory anemia

PLoS One. Authors: Carolina Vázquez, María Laura Gonzalez, Augusto Ferraris, Juan Carlos Bandi, and Marcelo Martín Serra.

This article is available for public use and does not require purchase. Click to view the full article.